Lv5
920 积分 2021-02-18 加入
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
19小时前
待确认
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2个月前
已完结
Personalized Neoantigen Vaccine and Pembrolizumab in Advanced Hepatocellular Carcinoma: A phase 1/2 trial
4个月前
已完结
A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma
4个月前
已完结
The changing landscape of cancer cell therapies: clinical trials and real-world data
4个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
5个月前
已完结
The diversity of CD8+ T cell dysfunction in cancer and viral infection
6个月前
已完结
RECIST 1.1—Update and clarification: From the RECIST committee
7个月前
已完结
Dendritic cells in cancer immunology and immunotherapy
7个月前
已完结
Personalized Neoantigen Vaccine and Pembrolizumab in Advanced Hepatocellular Carcinoma: A phase 1/2 trial
7个月前
已完结
皖公网安备34019202002308
